[Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection].
P. Cacoub(Sorbonne Université), Piette Jc, C. Françès(Navarre Institute of Health Research), Pierre Hausfater(Inserm), C Génesti, A Sbaï
PubMed
March 1, 2000
Cited by 38
Related Papers
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Pacemaker infective endocarditis
|The American Journal of Cardiology|1998|314
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258